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I. Introduction 
In gastrointestinal emergency situations we have to face countless difficulties and 
challenges. Many of the situation require immediate surgical interventions or intensive care 
unit (ICU) admission, and for most of them, special scoring systems were defined, to detect 
the severity of the disease or the worsening condition of the patient.  
Acute, severe gastrointestinal (GI) bleeding has previously required predominantly 
surgical care. Following the introduction and expansion of gastrointestinal endoscopy, the 
number of cases requiring surgery has dropped significantly. The incidence of upper non-
variceal bleeding and the need for operative intervention has been steadily declining since 
1993. Although endoscopic modalities have undergone significant development, it can be said 
that we have not been able to achieve a significant improvement in the mortality of 
gastrointestinal bleeding in the last decades. Possible reasons are the significant increase in 
the average age of the population and fatal outcomes due to the many comorbidities 
associated mostly with old age. It is often seen that GI bleeding can be stopped in a patient, 
yet the outcome is fatal. Accordingly, a reduction in mortality rates in the future will be 
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possible if patient management, independent of endoscopic techniques can be improved. The 
key is to have a proper risk assessment and to pay more attention to the treatment of 
vulnerable patients (early, accurate risk assessment, closer observation, multi-parameter 
monitoring). There are several risk assessment and outcome predictor scoring systems, most 
of which rely on clinical parameters typical of the acute phase of bleeding. The Rockall 
scoring system calculates outcome based on comorbidities, however, e.g. in terms of renal 
failure, the stages are not properly defined. 
Acute pancreatitis (AP) is a leading cause of hospital admissions worldwide. The 
disease can be traced back to various causes, which can vary in severity. According to the 
severity of the disease, we distinguish between mild, moderate and severe cases. Mortality in 
severe cases is much higher, approximately 30%.  As the mortality of severe cases is high, the 
disease has been in the focus of research in recent decades. As a result, there is a significant 
improvement in mortality, but it is still high. Different scoring systems try to predict the 
outcome of cases with more or less success. Subsequent complications are not taken into 
account by these scoring systems. Accordingly, they do not clarify the effect of the case on 
the outcome. The modified Marshall scoring system takes multiple organ system dysfunctions 
into account, which are strongly correlated with mortality and ICU admission. Three major 
organ systems are highlighted i.e., renal, cardiovascular, and respiratory failure formation are 
the most frequently researched and articles on topics, while neurological complications and 
regular use of the Glasgow Coma Scale (GCS) have been pushed into the background. In 
clinical practice, patients hospitalized for acute pancreatitis may have or may be formed 
neurological symptoms such as alcohol withdrawal syndrome, confusion and delirium. 
Disorder of consciousness means the development of spatial and temporal disorientation, it 
often occurs in hospitalized patients, especially the elderly. The currently used prognostic 
score systems do not take into account the disturbances of consciousness developed during 
hospital admission, so they cannot estimate their effect on the course of the disease. 
Treatment of AP is predominantly supportive, accordingly, if complications can be reduced 
with adequate patient care, it can also improve the outcome.  
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II. Pre-existing chronic kidney disease and GI bleeding 
II.1 Hypotheses/Aims 
Pre-existing chronic kidney disease may worsen the prognosis in gastrointestinal bleeding. 
We performed this meta-analysis to compare chronic kidney disease patients and normal renal 
function patients based on gastrointestinal bleeding. We investigated these two groups in 
terms of mortality, transfusion amount, rebleeding rate and length of hospitalization. 
II.2 Methods 
This study was conducted using the preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P). It was registered in the international prospective register of 
systematic reviews, PROSPERO (under registration number CRD42017077987). The meta-
analysis was based on the PICO (Patient, Intervention, Comparison, Outcome) format (P: 
patients with GI bleeding; I: chronic renal failure; C: normal renal function; O: mortality, 
blood transfusion, rebleeding). A systematic search was performed in 3 databases, Pubmed, 
EMBASE and the Cochrane Library, with the following terms: (“GI bleeding” OR 
“gastrointestinal bleeding” OR “gastrointestinal hemorrhage”) AND (“chronic renal failure” 
OR “uremia” OR “chronic kidney failure”). The search was limited to human data and to full-
text English-language articles if appropriate. The exact search term in Pubmed was: [“GI 
bleeding”(All Fields) OR “gastrointestinal bleeding”(All Fields) OR “gastrointestinal 
hemorrhage”(All Fields)] AND [“chronic renal failure”(All Fields) OR “uraemia”(All Fields) 
OR “uremia”(MeSH Terms) OR “uremia”(All Fields) OR “chronic kidney failure”(All 
Fields)] AND [“humans”(MeSH Terms) AND English(lang)]. The database search was 
conducted up to 10 March 2017. Reference management software (EndNote X7) was used to 
remove duplicates by searching overlaps between titles, authors and publication years. The 
reference lists in the articles obtained were also checked, and one more eligible publication 
was found. 
The studies were selected separately by two investigators (RH and AM). Disagreements were 
resolved by consulting a third reviewer (PH). Clinical studies were eligible provided they 
reported data on adult patients hospitalized with upper or lower GI bleeding grouped into 
normal renal function and CKD or end-stage renal disease (ESRD) groups. Articles were 
eligible containing data of CKD/ESRD patients and a control group in the same study. 
Information on mortality, transfusion, rebleeding and length of hospitalization (LOH) was 
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manually searched. Case reports, conference abstracts, reviews and studies on pediatric 
patients up to age 18 alone were excluded. We found a high number of articles in which the 
risk of GI bleeding in CKD patients was studied, but they were not eligible for our meta-
analysis, as there were no data available on outcomes of the GI bleeding in a control 
population without CKD/ESRD. Mortality data, number of transfused blood units, rebleeding 
and length of hospitalization data were extracted to analyse the influence of CKD and/or 
ESRD on the outcome of GI bleeding. All meta-analytic calculations were performed with 
Comprehensive Meta-Analysis software (Version 3.0, Biostat Inc.) using the random-effects 
model (DerSimonian-Laird method). Odds ratios (OR) and 95% confidence intervals (CI) 
were calculated for binary outcomes. In the case of LOH and transfusion for comparing mean 
data, a mean difference (MD) with 95%CI was calculated. All analyses were two-tailed, with 
an α of 0.05. Heterogeneity was tested using Cochrane’s Q and the I2 statistics. Based on the 
Cochrane Handbook, I2 = 100% × (Q - df)/Q, with I2 representing the magnitude of the 
heterogeneity (moderate: 30%-60%; substantial: 50%-90%; considerable: 75%-100%). Only 
results that were available from at least 3 studies were displayed graphically with forest plots. 
We performed a sensitivity analysis to assess whether removing any study results in different 
interpretations and final conclusions. To assess the effect of the year of publication on the 
outcome data we performed meta-regression analysis. We calculated the regression 
coefficient and interpreted the data with their 95%CI and r-analog. Because of the low 
number of eligible articles, publication bias was obtained with a visual inspection of the 
funnel plots alone according to the Cochrane Handbook. The Newcastle-Ottawa Scale (NOS) 
adjusted to our study design was used to assess the quality of nonrandomized cohort studies. 
The selection, comparability and outcome data were assessed based on 6 items with the “star 
system”: high-quality items with a low risk of bias received one star, while low-quality items 
with a high or unknown risk of bias were assigned no stars. 
3 items were included during the selection process. In the case of representativeness in the 
study population, we assigned a star if all of the GI bleeding patients with normal or impaired 
renal function were included. If any selection criteria were applied, we assigned no points. We 
used the classical definition of CKD, which characterizes the disease with a glomerular 
filtration rate (GFR) < 60 mL/min lasting longer than 3 mo. ESRD was defined as a condition 
where hemodialysis or chronic peritoneal dialysis is performed for at least 3 mo. Concerning 
outcome, only the follow-up time for rebleeding was rated in articles that provided this 
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information. Assessment of outcome and length of follow-up were not rated because most of 
the articles were retrospective. 
II.3 Results 
1063 articles (EMBASE: 589; PubMed: 459; Cochrane: 15) were found altogether through 
database searches. Studies in our meta-analysis were dated from 1946 to 2017. After 
removing duplicates, 875 publications remained. Following initial screening based on titles 
and abstracts, 23 articles were retrieved and screened. A further 18 were excluded because of 
missing outcome data or a missing control group. The remaining 5 and one other eligible 
record which was found in reference lists were included in the meta-analysis. These 6 
publications contained data on 406,035 patients, of whom 51315 had impaired renal function 
parameters and 354720 had normal renal functions. 2 articles contained data on patients with 
CKD and 4 on ESRD patients. There were 2 studies involving CKD and ESRD patients, with 
their group identified as the CKD mixed group. The number of ESRD patients analysed was 
15201, the CKD group had 36035 members, and 79 patients could be classified in the CKD 
mixed group. Data on mortality was available in all of the articles included. In the subgroup 
analysis for CKD and ESRD, a higher mortality rate was detected compared to the control 
population (CKD: OR = 1.786, 95%CI: 1.689-1.888, P < 0.001; ESRD: OR = 2.530, 95%CI: 
1.386-4.616, P = 0.002). 4 studies reported data on the transfused units of red blood cells. The 
required transfusion was 1.8 times higher in the patients with abnormal renal function (MD = 
1.863, 95%CI: 0.812-2.915, P < 0.001). It was possible to retrieve data on the rebleeding rate 
from 3 articles. We found that patients with impaired renal function tend to bleed again 2.5 
more times than patients with normal renal function (OR = 2.510, 95%CI: 1.521-4.144, P < 
0.001). Two of the six articles included reported hospital stay outcomes. Patients with 
impaired renal function spent significantly more time in hospital after GI bleeding (MD = 
13.245, 95%CI: 6.886-19.623, P < 0.001). High heterogeneity was detected for mortality in 
the ESRD group (Q = 17.082; DF = 3; I2 = 82.438%; P < 0.001), while the heterogeneity for 
CKD was low (Q = 1.767; DF = 2; I2 = 0%; P = 0.413). However, a low heterogeneity was 
detected for the transfusion requirements (Q = 3.448; DF = 3; I2 = 13.003%; P = 0.328), the 
rebleeding rate (Q = 3.328; DF = 3; I2 = 9.845%; P = 0.344) and LOH (Q = 1.100; DF = 
2; I2 = 0%; P = 0.577). Meta-regression showed slight significance, in the most recent articles 
the OR is decreasing with the time (regression coefficient: b = -0.0548; 95%CI: -0.0968 to -
0.0128; P = 0.0105; r-analog: 0.2. The number of required units for transfusion has not 
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changed since the 1980s (b = -0.0028; 95%CI: -0.0242 to -0.0186; P = 0.7972; r-analog: 
0.00). Based on data from 4 articles, no difference in rebleeding rate could be observed in the 
last 30 years (b = 0.0027; 95%CI: -0.0353 to 0.03; P = 0.8726; r-analog: 0.00).With regard to 
ascertaining exposure, 33% of the articles represented a low risk of bias, while 66% had an 
unclear risk of bias. In these articles CKD and ESRD were not clearly defined, or patients 
were sorted based on a code system.  
 
II.4 Discussion 
CKD is a term that covers all degrees of decreased renal function (mild, moderate, and severe 
chronic kidney disease), where the GFR is lower than 60 mL/min for longer than 3 mo. CKD 
is a worldwide public health problem, with both incidence and prevalence rising and the main 
causes being diabetes mellitus and high blood pressure. ESRD patients requiring hemodialysis 
or peritoneal dialysis represent a high burden and cost for the health care system. As the 
prevalence of hypertension and diabetes mellitus, the most important etiological factors for 
CKD and ESRD is increasing worldwide, we predict that GI bleeding with CKD will be a 
growing problem. The number of patients on hemodialysis has tripled between 1990 and 
2010. This is the first meta-analysis to report on the severity of complications after GI 
bleeding in patients with CKD or ESRD and normal renal function groups. Based on a 
systematic search in 3 databases, we were able to include 6 articles, which contained data on 
406035 patients, of whom 51315 had impaired renal function. A higher prevalence of peptic 
ulcers was reported among ESRD patients undergoing long-term dialysis. The elevated risk 
for GI bleeding in CKD and ESRD patients is also well known. The most frequent causes of 
lower GI bleeding in this population have been described; diverticulosis, hemorrhoids, and 
ischaemic colitis have been identified in addition to angioectasias, but no cohort study has 
been conducted on this topic yet. Although we did not intend to narrow our search to upper GI 
bleeding, the articles eligible for our inclusion criteria contained data only on patients with 
upper GI bleeding, and no studies with lower GI bleeding met our inclusion criteria. Only a 
few of the studies detailed the endoscopic findings and cause of bleeding. Based on the 
pooled data, we found that ESRD increases mortality 2.5 times while CKD increases it 1.8 
times in GI bleeding compared to the controls with normal renal function, but these ORs are 
not significantly different. Based on the result of the meta-regression the mortality-rate of GI 
bleeding has improved since the 1980s. It is likely one of the reasons for the heterogeneity of 
the data. Inhomogen patient groups also result in a significant bias. However, the sensitivity 
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analysis showed that none of the articles influences significantly the pooled OR. Volume 
replacement and blood transfusion are important parts of the therapy of GI bleeding. This 
meta-analysis demonstrated that patients with chronic impaired renal function develop 2.5 
times more rebleeding episodes and require almost 2 more red blood cell units for transfusion 
than the control group. Patients with impaired renal function spent more time in the hospital 
than the control group. There are several limitations to this study; therefore, the results of this 
meta-analysis should be regarded with caution. Unfortunately, only a low number of articles 
was found on this topic, with half of them written in the 1980s and 1990s. In the recent 
articles, CKD and ESRD groups were separated, but in the earlier publications these groups 
were mixed, leading to a bias in our analysis, and the definition of GFR was also not 
mentioned. The diagnosis was based on elevated creatinine level. Publications with rebleeding 
data did not follow patients for the same time interval, and 1 paper did not report on the 
follow-up time. The strength of this meta-analysis is the high number of patients. Our results 
have demonstrated that patients with ESRD show higher mortality during GI bleeding. CKD 
patients require more transfusion, and the rebleeding rate is also more elevated than that in 
patients with normal renal function. Because of these severe conditions, the LOH is also 
longer. Patients with ESRD or CKD should be observed more carefully due to the elevated 
complication rate. In this meta-analysis, we wanted to highlight the importance of this clinical 
problem and we believe that it needs further scientific research. In order to understand the 
effect of CKD/ESRD and other comorbidities on the outcomes of GI bleeding in more details, 
observational trials, and registries on GI bleeding should be developed. 
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III. Disturbance of consciousness and acute pancreatitis 
III.1 Aims/Hypothesis 
Based on literature data, AP has several aggravating factors that worsen survival parameters. 
Of these factors predisposing to a negative outcome, we targeted disturbances of 
consciousness in our research because the literature in this area is incomplete.  
Hypothesis 1. In case of development of disturbance of consciousness during hospitalization, 
the course of pancreatitis will be more severe, and LOH longer.  
Hypothesis 2. The development of disturbance of consciousness is associated with more 
severe AP, thereby increasing the mortality of the underlying disease. To verify our 
assumptions, we performed an analysis of HPSG prospective register data.  
 
III.2 Methods 
The Hungarian Pancreatic Study Group (HPSG) established a prospective international 
registry containing AP patients’ data. For this HPSG cohort study data of 1220 patients were 
used, since they contained data about the level of consciousness during hospitalization. Data 
were collected between January 2013 and January 2017. Based on the presence of DOC, 
patients were sorted into DOC and Non-DOC groups. The DOC group was further divided 
into alcohol-related DOC (ALC DOC) and non-alcohol-related DOC (Non-ALC DOC). DOC 
was diagnosed if the patient had confusion, disorientation, memory deficit, hyper- or 
hypoactivity, or symptoms of alcohol withdrawal such as anxiety, shaky hands, headache, 
insomnia or sweating, or epileptic seizure; or signs of delirium. The information of DOC was 
collected from the prospectively collected database of the HPSG registry and the patients’ 
documentation, answering a post hoc defined research question. In severe cases, the 
documentation also included psychiatric consultation. Descriptive statistical tools were used 
to characterize our cohort. To examine differences between the groups, in case of age, we 
used an independent sample t-test, whereas the length of hospitalization (LOH) with the 
Mann-Whitney test were analyzed. To analyze the connection between severity, mortality, 
and DOC, and between the time of onset of DOC and severity, the Chi-squared test or Fisher 
exact test was performed. All statistical analyses were done using SPSS Ver. 24 Software 
(IBM Corporation Armonk, New York). The significance level was set at 0.05.  




A total of 1220 cases from 20 centers were analyzed. Data were complete for age, gender, 
etiology of pancreatitis, LOH, the severity of acute pancreatitis, and mortality. Our registry 
included data about alcohol consumption in 99.6%. More than half of our patients were male 
(n: 683), and 46% were female (n: 537). The most common etiological factor was biliary 
pancreatitis (38.4%, n: 469), followed by idiopathic (19.2%, n: 234), and alcohol-induced 
pancreatitis (15.2%, n: 186). In the case of acute alcoholic pancreatitis, male dominance can 
be seen (male 87%, n: 162; female 13%, n: 24). Moderate pancreatitis was observed in 26.7% 
of cases and severe inflammation in 5.8% of the cases. The LOH was almost three times more 
(23.5 days ± 2.5) in case of severe acute pancreatitis than in mild ones (8.6 days ± 0.17). In 
moderate cases, the average LOH was 18 ± 0.7 days. The total mortality rate was 2.4%. In 
severe cases, the mortality reached 29.9%, in mild cases, 0.2% only, and in moderate cases, 
2.2%. From the 1220 patients of the HPSG registry, 47 patients (3.9%) developed DOC. 
Based on the type of DOC, delirium (n: 18), confusion (n: 16), alcohol withdrawal syndrome 
(n: 9), and convulsion (n: 3) groups were identified. According to the etiology of DOC, in our 
cohort, alcohol (n: 23), older age (n: 9), and sepsis (n: 6) caused the most cases of DOC. 
However, ischemia (n: 3) hypoglycemia (n: 1) and electrolyte imbalance (n: 1) also caused 
DOC. In addition, 4 cases were idiopathic. The male ratio was 55.4% (n: 650) in the Non-
DOC group, while 70.2% (n: 33) in the DOC group. The presence of DOC showed a higher 
incidence in men than in women (70.2% vs. 29.8%, n: 33 vs. n: 14, p: 0.045). The age 
differed significantly between the groups; in the DOC group, the subjects were older (62.2 ± 
18.7 vs. 56.5 ± 17 years, p: 0.025). From the registered 47 patients with DOC, 23 (48.9%) 
cases were ALC DOC, whereas 24 (51.1%) cases were Non-ALC DOC. In the ALC DOC 
group, the delirium was present more often than in the Non-ALC DOC group (n: 12 vs. n: 7), 
while in the Non-ALC group, the confusion with milder clinical features was more often 
present (n: 15). ALC DOC showed a significant correlation with gender. It developed more 
frequently in men than women (91.3% vs. 8.7%; n: 21 vs. n: 2; p: 0.002), while in Non-ALC 
DOC, no difference was seen between the genders. Patients with Non-ALC DOC were older 
than patients with ALC DOC (70.5 ± 18.4 vs. 53.5 ± 15 years, p: 0.002). Severity and 
mortality of AP and LOH in DOC vs. Non-DOC groups. Analysis between the DOC and 
Non-DOC groups showed higher incidence of severe AP (19.2% vs. 5.3%,. n: 9/47 vs. n: 
62/1173, p < 0.001), 8.8 times higher mortality (14.9% vs.1.7%, n: 7/ 47 vs. n: 20/1173, p < 
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0.001), and a longer LOH in the DOC group (Me: 11; IQR: 8-17 days vs. Me: 9; IQR: 6-13 
days, p: 0.049) respectively. Severity and mortality of AP and LOH in ALC DOC vs. Non-
ALC DOC groups. Moderate AP developed more frequent in patients with ALC DOC vs. 
Non-ALC DOC group (43.5% vs. 12.5% n: 10 vs. n: 3) while the incidence of severe AP was 
7 times higher in Non-ALC vs. ALC DOC group (33.3% vs. 4.4%, n: 8 vs. n: 1), p < 0.001. 
Mortality showed no difference between the analyzed groups (n: 3 vs. n: 4). Concerning the 
LOH, patients with Non-ALC DOC showed a tendency for longer hospitalization (Me: 13; 
IQR: 7-20 days vs. Me: 9.5; IQR: 8-15.5 days, p: 0.119). 
 
III.4 Discussion 
Hospital-acquired delirium often remains unnoticed, because its symptoms resemble dementia 
and depression, further complicating the diagnosis. Not surprising that no data is available 
concerning the relationship of DOC and the outcome of AP. Here we show for the first time 
that DOC is associated with more severe and higher mortality rates of AP. The question 
arises, which factor comes first, the severe AP, or the DOC. It is possible that due to AP 
released metabolic mediators, hypovolemia and systemic inflammatory response syndrome 
may lead to different organ failures, such as encephalopathy. On the other hand, in a patient 
with chronic alcohol consumption during hospitalization with mild AP (based on Atlanta 
classification), delirium tremens may occur, which is a severe illness in itself, which can lead 
to multi-organ failure, ICU admission, and mechanical ventilation. It is also important to 
mention that the development of delirium increases the mortality risk in the ICU, and it is also 
associated with longer ICU-stay. We found that moderate pancreatitis is more common in the 
ALC DOC group, whereas in the Non-ALC DOC group, more severe cases were detected. 
There was no difference in the mortality rate in the ALC DOC and Non-ALC DOC groups. 
However, there was a lower rate of severe AP in the ALC group; it had the same mortality 
rate. This difference may be explained by the fact that, in the ALC DOC group, chronic 
alcohol consumption is higher. These individuals are of lower social standing, with lower 
income, often malnourished, have vitamin deficiencies, cachexia/ sarcopenia, and are at 
various stages of liver cirrhosis, all of which can lead to higher mortality in moderate AP. The 
other suggestion is that DOC influences mortality regardless of etiology. The findings of this 
study have some limitations. Based on the cohort analysis, there was a difference in the 
demographic parameters, which may influence our results. Also, between the DOC and Non-
DOC and between the ALC and Non-ALC DOC groups’ differences in gender were seen; 
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however, in the ALC DOC group, the gender distribution in alcoholic AP confirms these 
results. In the DOC and Non-ALC DOC groups, the average age is higher, which may have a 
causal role in the more severe course of the disease. Besides, based on the analysis method, no 
conclusion, according to the casualty of DOC and severity could be shown, only associations 
between the parameters can be provided.  
Benzodiazepines are currently in the first-line treatment for alcohol withdrawal syndrome. 
They significantly reduce the risk of recurrent seizures related to alcohol withdrawal 
compared to placebo. Despite the high prevalence rate of delirium and the marked 
deteriorating effects on the outcome of the different illnesses, the management of delirium 
lacks unified professional guidelines. 
 
IV. Conclusions 
This PhD work deals with the outcomes of two major GI disease, with GI bleeding and acute 
pancreatitis. In these life-threatening diseases a proper risk assessment is needed to detect the 
potential instabile and vulnerable patients.   
According GI bleeding, there are several risk assessment and outcome predictor scoring 
systems which calculates outcome based on comorbidities, however, e.g. in terms of renal 
failure, the stages are not properly defined. Our work is the first meta-analysis and systematic 
review in this topic, which quantifies CKD as a negative risk factor in GI bleeding. GI 
bleeding in patients with chronic renal failure significantly increases the mortality rate, 
rebleeding rate, LOH, and they require more blood transfusion compared to patients with 
normal kidney functions. Kidney disease significantly worsens the outlook of patients 
presenting with GI bleeding. Patients with CKD will need to be treated with more caution due 
to the worse outcomes of GI bleeding. Although CKD, ESRD, and other comorbidities are 
major risk factors for unfavorable outcomes in GI bleeding, their roles are not well 
investigated nor understood and they need further scrutiny. We would better understand the 
role of CKD in ESRD in GI bleeding from analysis of extensive data from large multicenter 
and multinational observational studies and registries accurately recording the outcomes and 
the kidney functions. 
Disorder of consciousness may develop in AP, but there is no literature about the influence of 
DOC on the outcome of AP. This is the first cohort analysis from the HPSG registry data, 
which showed that DOC is associated with a more severe course of AP, these patients 
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requires longer LOH. In these patients a higher mortality rate of the underlying disease. 
Alcohol consumption in medical history elevates the rate of moderate AP in the DOC group. 
As a clinical implication, according to our data, we can conclude that the onset of DOC is a 
negative prognostic factor in the outcome of AP. To answer this clinical question, it is 
necessary to organize an observational clinical trial to monitor all relevant parameters for 
DOC continuously. This observational clinical study could prove the real causal relationship 
between DOC and the outcomes of AP. Furthermore, if the observational study confirms our 
data, randomized clinical trials aiming to prevent DOC should be organized. Our data suggest 
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